<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K/A
AMENDMENT NO. 1
(Mark One)
X ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
- EXCHANGE ACT OF 1934
FOR THE FISCAL YEAR ENDED: OCTOBER 2, 1999
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM TO
COMMISSION FILE NUMBER: 0-5255
COHERENT, INC.
(Exact name of registrant as specified in its charter)
DELAWARE 94-1622541
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
5100 PATRICK HENRY DRIVE, SANTA CLARA, CALIFORNIA
95054 (Address of principal executive offices,
including zip code)
(408) 764-4000
(Registrant's telephone number, including area code)
Securities registered pursuant to Section 12(b) of the
Act: NONE Securities registered pursuant to Section
12(g) of the Act:
COMMON STOCK, $.01 PAR VALUE PER SHARE
COMMON STOCK PURCHASE RIGHTS
(Title of Class)
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
Registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes X No
Indicate by check mark if disclosure of delinquent filers pursuant to
Item 405 of Regulation S-K is not contained herein, and will not be contained,
to the best of Registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K or any
amendment to this Form 10-K. X
As of January 12, 2000, 24,737,835 shares of Common Stock were
outstanding. The aggregate market value of the voting shares (based upon the
closing price reported by the Nasdaq National Market on January 12, 2000) of
Coherent, Inc., held by nonaffiliates was $619,844,888.00 . For purposes of this
disclosure, shares of Common Stock held by persons who own 5% or more of the
outstanding Common Stock and shares of Common Stock held by each officer and
director have been excluded in that such persons may be deemed to be
"affiliates" as that term is defined under the Rules and Regulations of the Act.
This determination of affiliate status is not necessarily conclusive.
DOCUMENTS INCORPORATED BY REFERENCE
None.
EXPLANATORY NOTE
This Annual Report on Form 10-K/A ("Form 10-K/A") is being filed as
Amendment No. 1 to the Registrant's Annual Report on Form 10-K for the fiscal
year ended October 2, 1999. This Form 10-K/A is filed with the Securities and
Exchange Commission (the "Commission") solely for the purpose of revising and
restating the following items in their entirety.
<PAGE>
PART III
ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE COMPANY
DIRECTORS
The names of the directors of the Company and certain information about
them are set forth below.
<TABLE>
<CAPTION>
NAME OF DIRECTOR AGE DIRECTOR PRINCIPAL OCCUPATION
SINCE
<S> <C> <C> <C>
Bernard J. Couillaud (3) 55 1996 President and Chief Executive Officer of the Company
Henry E. Gauthier (1)(2)(3) 59 1983 Chairman of the Board of Directors of the Company
Charles W. Cantoni (1)(2)(3) 64 1983 Owner, Cantoni Consulting
Frank P. Carrubba (1)(2)(3) 62 1989 Retired Chief Technical Officer, Phillips Electronics N.V.
Thomas Sloan Nelsen (1)(2) 73 1983 Retired Professor of Surgery, Stanford University School of
Medicine
Jerry E. Robertson (1)(2) 67 1994 Retired Executive Vice President, 3M Life Sciences Sector
and Corporate Services
</TABLE>
(1) Member of the Compensation Committee.
(2) Member of the Audit Committee.
(3) Member of the Nominating Committee
Except as set forth below, each of the nominees has been engaged in his
principal occupation set forth above during the past five years. There is no
family relationship between any director or executive officer of the Company.
Mr. Gauthier retired as President and COO of the Company in July 1996.
Mr. Cantoni is the owner of Cantoni Consulting and provides management
and medical marketing consulting services. Prior to founding Cantoni Consulting,
Mr. Cantoni was Vice President, Quinton Instruments, Inc., a manufacturer of
medical instrumentation products, a position he has held since October 1994.
From August 1988 until September 1994, he was President of ImageComm Systems,
Inc., a value added reseller of medical image processing systems.
Mr. Robertson retired from 3M in 1994. He is a member of the board
of directors of Cardinal Health, Inc., Steris Corporation, and Choice Hotels
International.
Mr. Couillaud is President and Chief Executive Officer as well as a
member of the Board of Directors since July 1996. He served as Vice President
and General Manager of Coherent Laser Group from March 1992 to July 1996. From
1990 to March 30, 1992, he served as Manager of the Advanced Systems Business
Unit, and from 1987 to 1990 served as Director of R&D for the Coherent Laser
Group.
-2-
<PAGE>
OFFICERS
The names, ages and office of all of the executive officers of the
Company are set forth below.
<TABLE>
<CAPTION>
NAME OF OFFICER AGE OFFICE HELD
<S> <C> <C>
Bernard J. Couillaud 55 President and Chief Executive Officer
Robert J. Quillinan 52 Executive Vice President and Chief Financial Officer
John R. Ambroseo 38 Executive Vice President and President, Coherent Laser Group
Vittorio Fossati-Bellani 52 Executive Vice President and President, Coherent
Semiconductor Group
James L. Taylor 50 Executive Vice President and President, Coherent Medical
Group
Scott H. Miller 45 Senior Vice President and General Counsel
Larry W. Sonsini 58 Secretary
</TABLE>
There are no family relationships between any of the executive officers
and directors.
Mr. Couillaud has served as President and Chief Executive Officer as
well as a member of the Board of Directors since July 1996. He served as Vice
President and General Manager of Coherent Laser Group from March 1992 to July
1996. From 1990 to March 30, 1992, he served as Manager of the Advanced Systems
Business Unit, and from 1987 to 1990, he served as Director of R&D for the
Coherent Laser Group.
Mr. Quillinan has served as Executive Vice President and Chief
Financial Officer since July 1984. He served as Vice President and Treasurer
from March 1982 to July 1984 and as Corporate Controller from April 1980 to
March 1982.
Mr. Ambroseo became Executive Vice President and President, Coherent
Laser Group in July 1997. He joined Coherent in 1988 as a Sales Engineer and has
served as Product Marketing Manager, U. S. Sales Manager, Director of
European Operations and most recently as Scientific Business Unit Manager.
Mr. Fossati-Bellani became Executive Vice President and President,
Coherent Semiconductor Group in July 1997. He joined the Italian office of
Coherent in 1979 as a Scientific Sales Engineer and has served in the capacity
of Product Manager, Director of Marketing, Director of Business Development,
Scientific Business Unit Manager and Diode Laser Business Unit Manager for the
Coherent Laser Group.
Mr. Taylor has served as Executive Vice President and President,
Coherent Medical Group since February 17, 1999.
Mr. Miller has served as General Counsel to the Company since October
1988 and as Senior Vice President since March 1994.
For over five years, Mr. Sonsini has served as the Company's Secretary
and a member of the law firm of Wilson, Sonsini, Goodrich & Rosati, P.C.
SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Section 16(a) of the Securities Exchange Act of 1934 requires the
Company's officers and directors, and persons who own more than ten percent of a
registered class of the Company's equity securities to file reports of ownership
and changes in ownership with the Securities and Exchange Commission (the "SEC")
and the National Association of Securities Dealers. Such officers, directors and
ten-percent stockholders are also required by SEC rules to furnish the Company
with copies of all forms that they file pursuant to Section 16(a). Based solely
on its review of the copies of such forms received by the Company, or on written
representations from certain reporting persons that no other reports were
required for such persons, the Company believes that, during fiscal 1999, its
officers, directors and ten-percent stockholders complied with all applicable
Section 16(a) filing requirements.
-3-
<PAGE>
ITEM 11. EXECUTIVE COMPENSATION
SUMMARY COMPENSATION
The following table shows, as to the Chief Executive Officer and each
of the other four most highly compensated executive officers whose salary plus
bonus exceeded $100,000, information concerning compensation awarded to, earned
by or paid for services to the Company in all capacities during the last three
fiscal years (to the extent that such person was the Chief Executive Officer
and/or executive officer, as the case may be, during any part of such fiscal
year):
<TABLE>
<CAPTION>
SUMMARY COMPENSATION TABLE
AWARDS ALL OTHER
NAME YEAR SALARY ($) BONUS ($) OPTIONS (#) COMPENSATION
<S> <C> <C> <C> <C> <C>
Bernard J. Couillaud 1999 $363,467 $302,571 60,000 $27,530 (1)
President and Chief Executive Officer 1998 337,492 147,578 138,000 23,393
1997 273,229 341,797 24,000 14,834
Robert J. Quillinan 1999 $222,665 $130,662 22,000 $15,067 (2)
Executive Vice President and 1998 220,201 65,138 34,000 14,723
Chief Financial Officer 1997 194,964 192,491 14,000 15,267
John Ambroseo 1999 $240,292 (3) $267,814 30,000 $13,714 (4)
Executive Vice President and 1998 206,898 (5) 108,668 36,000 8,672
President, Coherent Laser Group 1997 304,897 (6) 80,605 21,000 9,266
Vittorio Fossati-Bellani 1999 $189,566 $153,813 18,000 $11,998 (7)
Executive Vice President and 1998 178,288 46,669 24,000 11,207
President, Coherent Semiconductor Group 1997 127,515 77,693 19,500 9,537
Scott H. Miller 1999 $170,843 $84,489 8,000 $10,692 (8)
Senior Vice President and 1998 167,982 42,391 12,000 10,523
General Counsel 1997 153,877 132,780 7,000 12,154
</TABLE>
(1) Includes $20,249 contributed by the Company under defined contribution
plans and $7,281 in life insurance benefits.
(2) Includes $13,073 contributed by the Company under defined contribution
plans and $1,994 in life insurance benefits.
(3) Includes $10,779 compensation related to European assignment.
(4) Includes $13,171 contributed by the Company under defined contribution
plans and $543 in life insurance benefits
(5) Includes $19,282 compensation related to European assignment.
(6) Includes $186,162 compensation related to European assignment.
(7) Includes $10,363 contributed by the Company under defined contribution
plans and $1,635 in life insurance benefits.
(8) Includes $9,323 contributed by the Company under defined contribution
plans and $1,369 in life insurance benefits.
-4-
<PAGE>
STOCK OPTION GRANTS AND EXERCISES
The following table shows, as to the individuals named in the Summary
Compensation Table above, information concerning stock options granted during
the fiscal year ended October 2, 1999.
<TABLE>
<CAPTION>
OPTION GRANTS IN LAST FISCAL YEAR
INDIVIDUAL GRANTS
% OF TOTAL POTENTIAL REALIZABLE VALUE
NUMBER OF OPTIONS AT ASSUMED ANNUAL
SECURITIES GRANTED TO RATES OF STOCK PRICE
UNDERLYING EMPLOYEES APPRECIATION FOR
OPTIONS IN FISCAL EXERCISE EXPIRATION OPTION TERM (4)
NAME GRANTED (#) (1)(2) YEAR (3) PRICE ($/SH) DATE 5% ($) 10% ($)
<S> <C> <C> <C> <C> <C> <C>
Bernard J. Couillaud 6,299 .45 $15.875 6/14/05 $34,008 $77,154
53,701 3.86 $15.875 6/14/05 $289,933 $657,758
Robert J. Quillinan 6,299 .45 $15.875 6/14/05 $34,008 $77,154
15,701 1.13 $15.875 6/14/05 $84,770 $192,314
John Ambroseo 6,299 .45 $15.875 6/14/05 $34,008 $77,154
23,701 1.70 $15.875 6/14/05 $127,962 $290,302
Vittorio Fossati-Bellani 6,299 .45 $15.875 6/14/05 $34,008 $77,154
11,701 .84 $15.875 6/14/05 $63,174 $143,320
Scott H. Miller 6,299 .45 $15.875 6/14/05 $34,008 $77,154
1,701 .12 $15.875 6/14/05 $9,184 $20,835
</TABLE>
(1) The Company's 1987 Stock Option Plan and 1995 Stock Plan (collectively the
"Option Plans") provide for the grant of options and stock purchase rights
to officers, employees and consultants of the Company. Options granted
under the Option Plans may be either "nonstatutory options" or "incentive
stock options." The exercise price is determined by the Board of Directors
or its Compensation Committee and, in the case of incentive stock options,
may not be less than 100% of the fair market value of the Common Stock on
the date of grant (110% in the case of grants to 10% shareholders). The
options expire not more than six years from the date of grant and may be
exercised only while the optionee is employed by the Company or within
such period of time after termination of employment as is determined by
the Board or its Committee at the time of grant. The Board of Directors
may determine when options granted may be exercisable.
(2) The first entry for each individual sets forth the number of options
awarded that are intended to qualify as "incentive stock options" within
the meaning of Section 422 of the Internal Revenue Code of 1986. The
second entry for each individual sets forth the number of options that are
nonstatutory stock options.
(3) The Company granted options to purchase an aggregate of 1,391,100, to all
employees other than executive officers and granted options to purchase an
aggregate of 223,000 shares to all executive officers as a group (7
persons), during fiscal 1999.
(4) This column sets forth hypothetical gains or "option spreads" for the
options at the end of their respective ten-year terms, as calculated in
accordance with the rules of the Securities and Exchange Commission. Each
gain is based on an arbitrarily assumed annualized rate of compound
appreciation of the market price at the date of grant of 5% and 10% from
the date the option was granted to the end of the option term. The 5% and
10% rates of appreciation are specified by the rules of the Securities and
Exchange Commission and do not represent the Company's estimate or
projection of future Common Stock prices. The Company does not necessarily
agree that this method properly values an option. Actual gains, if any, on
option exercises are dependent on the future performance of the Company's
Common Stock and overall market conditions.
-5-
<PAGE>
The following table shows, as to the individuals named in the
Summary Compensation Table above, information concerning stock options exercised
during the fiscal year ended October 2, 1999 and the value of unexercised
options at such date.
<TABLE>
<CAPTION>
AGGREGATED OPTION EXERCISES IN LAST FISCAL YEAR
AND FISCAL YEAR-END OPTION VALUES
NUMBER OF SECURITIES
UNDERLYING UNEXERCISED VALUE OF UNEXERCISED
SHARES VALUE OPTIONS/SARS AT IN-THE-MONEY OPTIONS AT
ACQUIRED ON REALIZED OCTOBER 2, 1999 (#)(2) OCTOBER 2, 1999 ($)(3)
NAME EXERCISE (#) ($)(1) EXERCISABLE UNEXERCISABLE EXERCISABLE UNEXERCISABLE
<S> <C> <C> <C> <C> <C> <C>
Bernard J. Couillaud.......... 12,000 $78,000 96,000 180,000 $809,625 $1,566,000
Robert J. Quillinan........... 0 $0 32,000 62,000 $206,750 $468,875
John Ambroseo................. 0 $0 25,000 66,000 $119,188 $507,813
Vittorio Fossati-Bellani...... 8,500 $68,156 14,500 46,000 $7,250 $342,313
Scott H. Miller............... 5,000 $41,875 18,000 24,000 $157,000 $168,188
</TABLE>
(1) The value realized is calculated based on the closing price of the
Company's Common Stock as reported by the Nasdaq National Market on the
date of exercise minus the exercise price of the option, and does not
necessarily indicate that the optionee sold such stock.
(2) The Company has not granted any stock appreciation rights and its stock
plans do not provide for the granting of such rights.
(3) The market value of underlying securities is based on the difference
between the closing price of the Company's Common Stock on October 2, 1999
of $21.375 (as reported by Nasdaq National Market) and the exercise price.
DIRECTOR COMPENSATION
In fiscal year 1999, members of the Board of Directors who were not
employees of the Company received $16,000 plus $1,500 per meeting attended and
were reimbursed for their expenses incurred in attending such meetings.
The Company's 1990 Directors' Stock Option Plan (the "Directors' Option
Plan") was adopted by the Board of Directors on December 8, 1989 and was
approved by the stockholders on March 29, 1990. The Directors' Option Plan was
amended by the Board of Directors on January 25, 1996, and the amendment was
approved by the stockholders on March 20, 1996. The Directors' Option Plan
terminated on December 8, 1999 and no further options will be granted under this
plan. The Directors' Option Plan provides for the automatic and
non-discretionary grant of a non-statutory stock option to purchase 20,000
shares of the Company's Common Stock to each non-employee director on the later
of the effective date of the Directors' Option Plan or the date on which such
person becomes a director. Thereafter, each non-employee director will be
automatically granted a non-statutory stock option to purchase 5,000 shares of
Common Stock on the date of and immediately following each Annual Meeting of
Stockholders at which such non-employee director is reelected to serve on the
Board of Directors, if, on such date, he or she has served on the Board for at
least three months. Such plan provides that the exercise price shall be equal to
the fair market value of the Common Stock on the date of grant of the options.
The Company's 1998 Directors' Stock Option Plan (the "1998 Directors'
Plan") was adopted by the Board of Directors on November 24, 1998 and was
approved by the stockholders on March 17, 1999 and reserved 100,000 shares of
Common Stock for issuance thereunder. Under the terms of the 1998 Directors'
Plan, the number of shares is increased each year by the number of shares
necessary to restore the total number of shares reserved to 100,000 shares. The
1998 Director's Plan replaced the Directors' Option Plan which expired on
December 8, 1999. Like its predecessor, the 1998 Directors' Plan provides for
the automatic and non-discretionary grant of a non-statutory stock option to
purchase 20,000 shares of the Company's Common Stock to each non-employee
director on the date on which such person becomes a director. Thereafter, each
non-employee director will be automatically granted a non-statutory stock option
to purchase 5,000 shares of Common Stock on the date of and immediately
following each Annual Meeting of Stockholders at which such non-employee
director is reelected to serve on the Board of Directors, if, on such date, he
or she has served on the Board for at least three months. Such plan provides
that the exercise price shall be equal to the fair market value of the Common
Stock on the date of grant of the options. As of the fiscal year ended October
2, 1999, no options have been granted under the 1998 Directors' Plan.
Three non-employee directors have each been granted options to purchase
65,000 shares of the Company's Common Stock under such plan at a weighted
average exercise price of $11.62. One non-employee director has been
-6-
<PAGE>
granted options to purchase 45,000 shares of the Company's Common Stock under
such plan at a weighted average exercise price of $13.73 per share. One
non-employee director has been granted options to purchase 30,000 shares of the
Company's Common Stock under such plan at a weighted average exercise price of
$21.33 per share. As of January 12, 2000, 125,000 shares had been issued on
exercise of such options. The following table shows, as to each non-employee
director, information concerning options exercised under the Directors' Option
Plan during the last fiscal year:
<TABLE>
<CAPTION>
OPTION EXERCISES IN LAST FISCAL YEAR BY DIRECTORS
NAME SHARES ACQUIRED ON EXERCISE VALUE REALIZED(1)
<S> <S>
Charles W. Cantoni 5,000 $43,438
Frank Carrubba 5,000 $35,313
Thomas Sloan Nelsen 5,000 $30,625
</TABLE>
(1) The value realized is calculated based on market value less exercise
price. The market value of underlying securities is based on the closing
price of the Company's Common Stock as reported by the NASDAQ National
Market on the date of exercise.
COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION
The Compensation Committee is composed of Directors Gauthier,
Carrubba, Cantoni, Nelsen and Robertson. During the last fiscal year, the
Company paid Dr. Thomas Nelsen $63,000 in consulting fees. Dr. Nelsen has
more than 40 years of experience as a physician and, before his retirement,
was a Professor of Surgery at Stanford University School of Medicine.
Utilizing this experience, Dr. Nelsen has worked closely with the Company in
developing and refining new laser products for the medical field. Management
believes that this arrangement is at least as favorable as could be
negotiated with an outside consultant.
Mr. Gauthier and the Company have entered into a Management Transition
Agreement pursuant to which Mr. Gauthier has agreed to provide employment and
consulting services to the Company through June 30, 1999. In consideration for
these services, the Company agreed (i) to pay Mr. Gauthier his base salary
through June 30, 1997, (ii) to pay him an hourly consulting fee equal to $175.00
for services rendered through June 30, 1999, and (iii) to provide him with
benefits under the Company's medical, dental and life insurance plans.
OTHER EMPLOYEE BENEFIT PLANS
EMPLOYEE RETIREMENT AND INVESTMENT PLAN AND SUPPLEMENTARY RETIREMENT PLAN
Effective January 1, 1979, the Company adopted the Coherent Employee
Retirement and Investment Plan. Employees become eligible to participate after
completing one year of service. Under this plan, the Company will match employee
contributions to the plan up to a maximum of 6% of the employee's individual
earnings. An employee is not entitled to any part of the Company's contribution
until the completion of his or her third year of employment. After the end of
the third year of employment, 20% of the Company's contribution vests.
Thereafter, an additional 20% of the Company's contribution vests at the end of
each year of completed service until the end of the seventh year of employment
when such contributions become 100% vested. Effective as of 1985, the plan was
amended and restated to conform the plan to new regulations and to qualify under
Section 401(k) of the Internal Revenue Code of 1986, as amended to permit
employees to make contributions to the plan from their pre-tax earnings.
Effective January 1, 1990, the Company adopted the Supplementary Retirement Plan
which provides that certain senior management may contribute income to a trust
fund. The Company will match such contributions up to 6% of the participant's
income. Such contributions are subject to the same vesting requirements as
contributions made under the Employment Retirement and Investment Plan.
-7-
<PAGE>
MANAGEMENT BONUS PLAN
The Company's Management Bonus Plan provides for the payment of
quarterly cash bonuses to members of management designated by the Board of
Directors determined by a formula based on improvements of pre-tax profits, cash
flow and asset management over preset threshold levels for each operating group
or business unit. Those employees who participate in the Bonus Plan who are not
assigned to an operating group or business unit receive an average of such
amounts.
PRODUCTIVITY INCENTIVE PLAN
Under the Company's Productivity Incentive Plan (the "Incentive Plan"),
450,000 shares of Common Stock were initially reserved, and as of the fiscal
year ended October 2, 1999, 25,397 shares of Common Stock were available for
issuance to employees of the Company and its designated subsidiaries who are
customarily employed for at least twenty hours per week. The purpose of the
Incentive Plan is to enhance an employee's proprietary interest in the Company
and to create an incentive for the Company's success.
The Incentive Plan provides for the quarterly distribution of cash or
Common Stock, at the election of each participant, based upon the quarterly
profitability of the Company. The amount of cash or number of shares of Common
Stock distributed to each participant is determined by dividing a participant's
"incentive compensation" by the fair market value of the Company's Common Stock
at the end of each three-month period.
EMPLOYEE STOCK PURCHASE PLAN
The Company's Employee Stock Purchase Plan (the "Purchase Plan") was
adopted by the Board of Directors and approved by the stockholders in 1980. A
total of 4,575,000 shares of Common Stock have been reserved under the Purchase
Plan, and as of the end of fiscal year 1999, 2,222,836 shares of Common Stock
remained available for issuance thereunder. The Purchase Plan permits employees
who are employed for at least twenty hours per week and more than five months in
a calendar year to purchase Common Stock of the Company, through payroll
deductions at the lower of 85% of the fair market value of the Common Stock at
the beginning or at the end of each twelve-month period. Payroll deductions may
not exceed 10% of an employee's compensation. The Purchase Plan provides for two
offerings during each fiscal year, each having a duration of twelve months.
-8-
<PAGE>
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The following table sets forth as of January 12, 2000 certain
information with respect to the beneficial ownership of the Company's Common
Stock by (i) any person (including any "group" as that term is used in Section
13(d)(3) of the Securities Exchange Act of 1934, as amended (the "Exchange
Act")) known by the Company to be the beneficial owner of more than 5% of the
Company's voting securities, (ii) each director and each nominee for director to
the Company, (iii) each of the executive officers named in the Summary
Compensation Table appearing herein, and (iv) all executive officers and
directors of the Company as a group.
<TABLE>
<CAPTION>
NUMBER OF PERCENT
NAME AND ADDRESS SHARES (1) OF TOTAL
<S> <C> <C>
PRIMECAP Management (2)
225 S. Lake Ave, #400
Pasadena, CA 91101 2,420,000 9.78%
Franklin Templeton Group (3)
777 Mariners Blvd.
San Mateo, CA 94404 2,140,655 8.65%
Oppenheimer Funds, Inc. (4)
Two World Trade Center, 31st Floor
New York, NY 10048 2,085,000 8.43%
ICM Asset Mgmt (5)
601 W Main Ave. 1,465,980 5.93%
Spokane, WA 99201
Eagle Asset Management (6)
880 Carillon Pkwy., 3rd Floor
St. Petersburg, FL 33733 1,253,555 5.07%
Bernard, J. Couillaud (7) 140,626 *
Henry E. Gauthier (8) 107,330 *
Robert J. Quillinan (9) 73,678 *
Scott H. Miller (10) 49,598 *
Jerry E. Robertson (11) 35,000 *
John Ambroseo (12) 31,353 *
Vittorio Fossati-Bellani (13) 26,392 *
Frank Carrubba (14) 20,000 *
Thomas Sloan Nelsen (15) 17,000 *
Charles W. Cantoni (16) 10,000 *
All directors and executive officers as
a group (11 persons) (16) 530,977 2.15%
</TABLE>
* Represents less than 1%.
(1) Beneficial ownership is determined in accordance with the rules of the
Securities and Exchange commission (the "SEC") and generally includes
voting or investment power with respect to the securities. In computing the
number of shares beneficially owned by a person and the percentage
ownership of that person, each share of Coherent Common Stock subject to
options held by that person that will be exercisable on or before March 24,
2000, are deemed outstanding. Such shares, however, are not deemed
outstanding for the purpose of computing the percentage ownership of any
other person.
-9-
<PAGE>
(2) Represents shares reported by Carson Group on January 12, 2000 as being
held by PRIMECAP Management as of September 30, 1999.
(3) Represents shares reported by Carson Group on January 12, 2000 as being
held by Franklin Advisers, Inc. as of September 30, 1999.
(4) Represents shares reported by Carson Group on January 12, 2000 as being
held by Oppenheimer Funds, Inc. as of September 30, 1999.
(3) Represents shares reported by Carson Group on January 12, 2000 as being
held by ICM Asset Management as of September 30, 1999
(4) Represents shares reported by Carson Group on January 12, 2000 as being
held by Eagle Asset Management as of September 30, 1999.
(6) Includes 96,000 shares issuable upon exercise of options held by Mr.
Couillaud which are currently exercisable or will become exercisable within
60 days of January 12, 2000.
(7) Includes 54,000 shares issuable upon exercise of options held by Mr.
Gauthier which are currently exercisable or will become exercisable within
60 days of January 12, 2000.
(8) Includes 32,000 shares issuable upon exercise of options held by Mr.
Quillinan which are currently exercisable or will become exercisable within
60 days of January 12, 2000.
(9) Includes 18,000 shares issuable upon exercise of options held by Mr. Miller
which are currently exercisable or will become exercisable within 60 days
of January 12, 2000.
(10) Includes 10,000 shares issuable upon exercise of options held by Mr.
Robertson which are currently exercisable or will become exercisable within
60 days of January 12, 2000.
(11) Includes 12,000 shares issuable upon exercise of options held by Mr.
Ambroseo which are currently exercisable or will become exercisable within
60 days of January 12, 2000.
(12) Includes 14,500 shares issuable upon exercise of options held by Mr.
Fossati-Bellani which are currently exercisable or will become exercisable
within 60 days of January 12, 2000.
(13) Includes 5,000 shares issuable upon exercise of options held by Mr.
Carrubba which are currently exercisable or will become exercisable within
60 days of January 12, 2000.
(14) Includes 10,000 shares issuable upon exercise of options held by Dr. Nelsen
which are currently exercisable or will become exercisable within 60 days
of January 12, 2000.
(15) Includes 5,000 shares issuable upon exercise of options held by Mr. Cantoni
which are currently exercisable or will become exercisable within 60 days
of January 12, 2000.
(16) Includes an aggregate of 276,500 options which are currently exercisable or
will become exercisable within 60 days of January 12, 2000.
-10-
<PAGE>
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
The following table sets forth information with respect to all
executive officers of the Company who had indebtedness outstanding during the
past fiscal year. This indebtedness arose as a result of the delivery of
promissory notes in connection with the exercise of stock options.
<TABLE>
<CAPTION>
NAME NEW LOANS INTEREST MATURITY LARGEST BALANCE AT
DURING 1999 RATES DATE(S) AMOUNT OCTOBER 2,
OUTSTANDING 1999
DURING 1999
<S> <C> <C> <C> <C> <C>
Robert Quillinan - 5.68-5.69% 2/27/03-7/31/03 $325,779 $325,779
Bernard Couillaud $111,651 4.83% 3/1/04 $111,651 $111,651
Vittorio Fossati-Bellani $116,974 5.96% 8/31/04 $116,974 $116,974
Scott Miller $50,653 4.83-7.1% 10/4/99-3/1/04 $162,333 $162,333
</TABLE>
All promissory notes are full recourse and are secured by the shares of
Common Stock of the Company issued upon exercise of the options. Interest is
paid annually.
See "Executive Compensation -- Compensation Committee Interlocks and
Insider Participation" for a description of Dr. Nelsen's consulting arrangement
with the Company.
-11-
<PAGE>
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the Registrant has duly caused this Amendment No. 2 to
Form 10-K on Form 10-K/A to be signed on its behalf by the undersigned,
thereunto duly authorized on this 25st day of January 2000.
COHERENT, INC.
By: /S/ ROBERT J. QUILLINAN
-----------------------
Robert J. Quillinan
Executive Vice President & CFO
Pursuant to the requirements of the Securities Exchange Act of 1934,
this Amendment No. 2 to Form 10-K on Form 10-K/A has been signed below by the
following persons on January 25, 2000 on behalf of the Registrant and in the
capacities and on the dates indicated:
SIGNATURES TITLE
*
- Director, President & Chief Executive Officer
Bernard J. Couillaud (Principal Executive Officer)
* Executive Vice President & Chief Financial
- Officer
Robert J. Quillinan
*
- Director, Chairman of the Board
Henry E. Gauthier
*
- Director
Charles W. Cantoni
*
- Director
Frank Carrubba
*
- Director
Thomas Sloan Nelsen
*
- Director
Jerry E. Robertson
* By: /S/ROBERT J. QUILLINAN
----------------------
Robert J. Quillinan
Attorney-in-Fact
-12-
